PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34638000-5	2022	Additionally, we found that frontal levels of n-acetylaspartate relative to creatine (tNAA/tCr) were predicted by levels of t-tau.	N-acetylaspartate	46-63	microtubule associated protein tau	Homo sapiens	126-129	
21841259-2	2011	We tested the association of the putative marker of mitochondrial function N-acetylaspartate (NAA) as measured by proton magnetic resonance spectroscopy within the medial temporal lobe and cerebrospinal fluid amyoid-beta42 (Abeta42), total Tau and pTau181.	N-acetylaspartate	94-97	microtubule associated protein tau	Homo sapiens	240-243	
23579327-10	2013	Higher hippocampal NAA/Cr was related to higher CSF Abeta42, while lower parietal NAA/Cr was associated with a higher CSF total tau (t-tau) and p-tau181P.	N-acetylaspartate	82-85	microtubule associated protein tau	Homo sapiens	128-131	
23579327-10	2013	Higher hippocampal NAA/Cr was related to higher CSF Abeta42, while lower parietal NAA/Cr was associated with a higher CSF total tau (t-tau) and p-tau181P.	N-acetylaspartate	82-85	microtubule associated protein tau	Homo sapiens	135-138	
35038671-4	2022	An increase in posterior cingulate gyrus tau deposition, but not elevated Abeta, was associated with lower N-acetylaspartate/total creatine (tCr) and glutamate (Glu)/tCr ratios, and sex by tau interaction was observed in association with Glu/tCr.	N-acetylaspartate	107-124	microtubule associated protein tau	Homo sapiens	41-44	
31315971-7	2019	RESULTS: Asymptomatic MAPT mutation carriers had lower neuronal marker N-acetylaspartate (NAA)/creatine (Cr) (p = 0.001) and lower NAA/myo-inositol (mI) (p = 0.026) than noncarriers after adjustment for age.	N-acetylaspartate	71-88	microtubule associated protein tau	Homo sapiens	22-26	
31315971-7	2019	RESULTS: Asymptomatic MAPT mutation carriers had lower neuronal marker N-acetylaspartate (NAA)/creatine (Cr) (p = 0.001) and lower NAA/myo-inositol (mI) (p = 0.026) than noncarriers after adjustment for age.	N-acetylaspartate	90-93	microtubule associated protein tau	Homo sapiens	22-26	
31315971-7	2019	RESULTS: Asymptomatic MAPT mutation carriers had lower neuronal marker N-acetylaspartate (NAA)/creatine (Cr) (p = 0.001) and lower NAA/myo-inositol (mI) (p = 0.026) than noncarriers after adjustment for age.	N-acetylaspartate	131-134	microtubule associated protein tau	Homo sapiens	22-26	
31315971-8	2019	Symptomatic MAPT mutation carriers had lower NAA/Cr (p = 0.01) and NAA/mI (p = 0.01) and higher mI/Cr (p = 0.02) compared to noncarriers after adjustment for age.	N-acetylaspartate	45-48	microtubule associated protein tau	Homo sapiens	12-16	
31315971-8	2019	Symptomatic MAPT mutation carriers had lower NAA/Cr (p = 0.01) and NAA/mI (p = 0.01) and higher mI/Cr (p = 0.02) compared to noncarriers after adjustment for age.	N-acetylaspartate	67-70	microtubule associated protein tau	Homo sapiens	12-16